BVS
Price
$12.98
Change
-$0.08 (-0.61%)
Updated
Sep 11 closing price
Capitalization
886.6M
59 days until earnings call
Intraday BUY SELL Signals
ENOV
Price
$19.28
Change
+$0.87 (+4.73%)
Updated
Sep 11 closing price
Capitalization
1.11B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BVS vs ENOV

BVS vs ENOV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BVS vs. ENOV commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVS is a StrongBuy and ENOV is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENOV($1.11B) has a higher market cap than BVS($887M). BVS YTD gains are higher at: 74.462 vs. ENOV (-27.628). BVS has higher annual earnings (EBITDA): 104M vs. ENOV (-739M). BVS has more cash in the bank: 29.5M vs. ENOV (12.6M). BVS has less debt than ENOV: BVS (248M) vs ENOV (1.37B). ENOV has higher revenues than BVS: ENOV (2.3B) vs BVS (582M).
BVSENOVBVS / ENOV
Capitalization887M1.11B80%
EBITDA104M-739M-14%
Gain YTD74.462-27.628-270%
P/E Ratio16.64N/A-
Revenue582M2.3B25%
Total Cash29.5M12.6M234%
Total Debt248M1.37B18%
FUNDAMENTALS RATINGS
ENOV: Fundamental Ratings
ENOV
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BVSENOV
RSI
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 5 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 30 days ago
62%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
71%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (BVS: $12.98 vs. ENOV: $19.28)
Brand notoriety: BVS and ENOV are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BVS: 58% vs. ENOV: 196%
Market capitalization -- BVS: $886.6M vs. ENOV: $1.11B
BVS [@Medical/Nursing Services] is valued at $886.6M. ENOV’s [@Medical/Nursing Services] market capitalization is $1.11B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVS’s FA Score shows that 0 FA rating(s) are green while ENOV’s FA Score has 0 green FA rating(s).

  • BVS’s FA Score: 0 green, 5 red.
  • ENOV’s FA Score: 0 green, 5 red.
According to our system of comparison, BVS is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVS’s TA Score shows that 4 TA indicator(s) are bullish while ENOV’s TA Score has 5 bullish TA indicator(s).

  • BVS’s TA Score: 4 bullish, 5 bearish.
  • ENOV’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, BVS is a better buy in the short-term than ENOV.

Price Growth

BVS (@Medical/Nursing Services) experienced а -7.75% price change this week, while ENOV (@Medical/Nursing Services) price change was +3.88% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

BVS is expected to report earnings on Nov 10, 2026.

ENOV is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
BVS
Daily Signal:
Gain/Loss:
ENOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNFPX75.150.23
+0.31%
American Funds New Perspective 529-F-3
GQIRX59.23N/A
N/A
Goldman Sachs US Tax-Managed Eq Inv
DSCPX16.26N/A
N/A
Davenport Small Cap Focus
TROCX36.34N/A
N/A
Touchstone Non-US Equity I
TGVLX59.65N/A
N/A
Touchstone Dynamic Large Cap Growth R6